Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease
Autor: | Lubanda, Jean-Claude 1, *, Anijalg, Ene 2, Bzdúch, Vladimír 3, Thurberg, Beth L. 4, Bénichou, Bernard 5, Tylki-Szymanska, Anna 6 |
---|---|
Zdroj: | In Genetics in Medicine April 2009 11(4):256-264 |
Databáze: | ScienceDirect |
Externí odkaz: |